Fluorine in PDB 8fll: Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
Enzymatic activity of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
All present enzymatic activity of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib:
2.7.10.2;
Protein crystallography data
The structure of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib, PDB code: 8fll
was solved by
E.P.Cedervall,
C.K.Allerston,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
21.76 /
1.50
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
41.482,
67.269,
90.383,
90,
90,
90
|
R / Rfree (%)
|
18.5 /
20.2
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
(pdb code 8fll). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib, PDB code: 8fll:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 8fll
Go back to
Fluorine Binding Sites List in 8fll
Fluorine binding site 1 out
of 4 in the Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:25.1
occ:1.00
|
F16
|
A:Y7W701
|
0.0
|
25.1
|
1.0
|
C15
|
A:Y7W701
|
1.4
|
21.9
|
1.0
|
C17
|
A:Y7W701
|
2.3
|
20.1
|
1.0
|
C14
|
A:Y7W701
|
2.3
|
20.4
|
1.0
|
CE
|
A:MET449
|
2.9
|
29.3
|
0.6
|
SD
|
A:MET449
|
3.2
|
33.2
|
0.6
|
CB
|
A:LEU542
|
3.3
|
20.5
|
1.0
|
O
|
A:PHE540
|
3.4
|
18.8
|
1.0
|
CA
|
A:LEU542
|
3.4
|
20.1
|
1.0
|
N
|
A:LEU542
|
3.5
|
19.9
|
1.0
|
CE1
|
A:PHE442
|
3.6
|
29.3
|
1.0
|
C18
|
A:Y7W701
|
3.6
|
18.9
|
1.0
|
C13
|
A:Y7W701
|
3.6
|
19.5
|
1.0
|
CD1
|
A:LEU542
|
3.8
|
22.3
|
1.0
|
CE
|
A:MET449
|
3.9
|
35.4
|
0.4
|
C19
|
A:Y7W701
|
4.1
|
19.1
|
1.0
|
CG
|
A:LEU542
|
4.1
|
22.8
|
1.0
|
C
|
A:GLY541
|
4.1
|
21.1
|
1.0
|
C
|
A:PHE540
|
4.2
|
17.5
|
1.0
|
CZ
|
A:PHE442
|
4.2
|
29.5
|
1.0
|
C
|
A:ASP539
|
4.3
|
18.8
|
1.0
|
CG
|
A:MET449
|
4.3
|
29.6
|
0.6
|
O
|
A:ASP539
|
4.5
|
19.3
|
1.0
|
CG
|
A:MET449
|
4.5
|
27.0
|
0.4
|
CA
|
A:ASP539
|
4.5
|
19.1
|
1.0
|
N
|
A:PHE540
|
4.5
|
18.1
|
1.0
|
CD1
|
A:PHE442
|
4.6
|
29.0
|
1.0
|
O
|
A:GLY541
|
4.6
|
23.5
|
1.0
|
CD2
|
A:LEU542
|
4.6
|
24.4
|
1.0
|
C12
|
A:Y7W701
|
4.8
|
20.9
|
1.0
|
N
|
A:GLY541
|
4.8
|
18.3
|
1.0
|
CA
|
A:GLY541
|
4.8
|
19.5
|
1.0
|
O22
|
A:Y7W701
|
4.9
|
23.1
|
1.0
|
C
|
A:LEU542
|
4.9
|
21.1
|
1.0
|
SD
|
A:MET449
|
4.9
|
32.4
|
0.4
|
CA
|
A:PHE540
|
5.0
|
18.0
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 8fll
Go back to
Fluorine Binding Sites List in 8fll
Fluorine binding site 2 out
of 4 in the Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:21.9
occ:1.00
|
F30
|
A:Y7W701
|
0.0
|
21.9
|
1.0
|
C29
|
A:Y7W701
|
1.3
|
21.2
|
1.0
|
F31
|
A:Y7W701
|
2.1
|
22.5
|
1.0
|
F32
|
A:Y7W701
|
2.2
|
21.9
|
1.0
|
C27
|
A:Y7W701
|
2.3
|
18.0
|
1.0
|
N26
|
A:Y7W701
|
2.7
|
17.0
|
1.0
|
CB
|
A:LEU408
|
3.1
|
22.0
|
1.0
|
C33
|
A:Y7W701
|
3.3
|
16.9
|
1.0
|
N25
|
A:Y7W701
|
3.4
|
16.9
|
1.0
|
CB
|
A:VAL416
|
3.5
|
19.6
|
1.0
|
O
|
A:HOH925
|
3.5
|
25.4
|
1.0
|
N34
|
A:Y7W701
|
3.6
|
17.9
|
1.0
|
CG1
|
A:VAL416
|
3.6
|
20.3
|
1.0
|
C
|
A:LEU408
|
3.7
|
24.3
|
1.0
|
C28
|
A:Y7W701
|
3.7
|
18.6
|
1.0
|
O
|
A:LEU408
|
3.8
|
23.0
|
1.0
|
N
|
A:GLY409
|
3.9
|
25.3
|
1.0
|
CG2
|
A:VAL416
|
3.9
|
19.9
|
1.0
|
CA
|
A:LEU408
|
4.0
|
22.6
|
1.0
|
CD1
|
A:LEU408
|
4.1
|
22.2
|
1.0
|
CG
|
A:LEU408
|
4.2
|
22.1
|
1.0
|
C4
|
A:Y7W701
|
4.3
|
16.1
|
1.0
|
C5
|
A:Y7W701
|
4.3
|
16.4
|
1.0
|
CA
|
A:GLY409
|
4.3
|
26.4
|
1.0
|
C
|
A:GLY409
|
4.6
|
25.9
|
1.0
|
O
|
A:VAL416
|
4.7
|
19.9
|
1.0
|
O
|
A:GLY409
|
4.7
|
24.9
|
1.0
|
CA
|
A:VAL416
|
4.7
|
18.8
|
1.0
|
C
|
A:VAL416
|
5.0
|
19.0
|
1.0
|
O
|
A:HOH892
|
5.0
|
22.3
|
1.0
|
N
|
A:LEU408
|
5.0
|
23.9
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 8fll
Go back to
Fluorine Binding Sites List in 8fll
Fluorine binding site 3 out
of 4 in the Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:22.5
occ:1.00
|
F31
|
A:Y7W701
|
0.0
|
22.5
|
1.0
|
C29
|
A:Y7W701
|
1.3
|
21.2
|
1.0
|
F30
|
A:Y7W701
|
2.1
|
21.9
|
1.0
|
F32
|
A:Y7W701
|
2.2
|
21.9
|
1.0
|
C27
|
A:Y7W701
|
2.4
|
18.0
|
1.0
|
C28
|
A:Y7W701
|
2.9
|
18.6
|
1.0
|
N26
|
A:Y7W701
|
3.6
|
17.0
|
1.0
|
O
|
A:LEU408
|
3.6
|
23.0
|
1.0
|
O
|
A:HOH925
|
3.6
|
25.4
|
1.0
|
CA
|
A:GLY409
|
4.0
|
26.4
|
1.0
|
C
|
A:LEU408
|
4.0
|
24.3
|
1.0
|
N
|
A:GLY409
|
4.2
|
25.3
|
1.0
|
C
|
A:GLY409
|
4.3
|
25.9
|
1.0
|
N25
|
A:Y7W701
|
4.3
|
16.9
|
1.0
|
C33
|
A:Y7W701
|
4.5
|
16.9
|
1.0
|
CB
|
A:LEU408
|
4.6
|
22.0
|
1.0
|
N
|
A:THR410
|
4.6
|
26.9
|
1.0
|
N34
|
A:Y7W701
|
4.7
|
17.9
|
1.0
|
O
|
A:HOH827
|
4.9
|
42.0
|
1.0
|
CA
|
A:LEU408
|
5.0
|
22.6
|
1.0
|
O
|
A:GLY409
|
5.0
|
24.9
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 8fll
Go back to
Fluorine Binding Sites List in 8fll
Fluorine binding site 4 out
of 4 in the Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Btk Kinase Domain in Complex with Pirtobrutinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F701
b:21.9
occ:1.00
|
F32
|
A:Y7W701
|
0.0
|
21.9
|
1.0
|
C29
|
A:Y7W701
|
1.3
|
21.2
|
1.0
|
F30
|
A:Y7W701
|
2.2
|
21.9
|
1.0
|
F31
|
A:Y7W701
|
2.2
|
22.5
|
1.0
|
C27
|
A:Y7W701
|
2.4
|
18.0
|
1.0
|
C28
|
A:Y7W701
|
2.9
|
18.6
|
1.0
|
N26
|
A:Y7W701
|
2.9
|
17.0
|
1.0
|
N25
|
A:Y7W701
|
3.0
|
16.9
|
1.0
|
O
|
A:HOH892
|
3.2
|
22.3
|
1.0
|
CG2
|
A:VAL416
|
3.3
|
19.9
|
1.0
|
CB
|
A:VAL416
|
3.7
|
19.6
|
1.0
|
C33
|
A:Y7W701
|
4.1
|
16.9
|
1.0
|
C5
|
A:Y7W701
|
4.2
|
16.4
|
1.0
|
C
|
A:GLY409
|
4.3
|
25.9
|
1.0
|
CG1
|
A:VAL416
|
4.3
|
20.3
|
1.0
|
N
|
A:THR410
|
4.6
|
26.9
|
1.0
|
O
|
A:GLY409
|
4.6
|
24.9
|
1.0
|
CA
|
A:GLY409
|
4.7
|
26.4
|
1.0
|
C4
|
A:Y7W701
|
4.8
|
16.1
|
1.0
|
N
|
A:GLY409
|
4.8
|
25.3
|
1.0
|
O
|
A:THR410
|
4.9
|
29.3
|
1.0
|
N34
|
A:Y7W701
|
4.9
|
17.9
|
1.0
|
C
|
A:THR410
|
4.9
|
31.2
|
1.0
|
CA
|
A:VAL416
|
5.0
|
18.8
|
1.0
|
C6
|
A:Y7W701
|
5.0
|
16.1
|
1.0
|
CA
|
A:THR410
|
5.0
|
29.9
|
1.0
|
|
Reference:
E.B.Gomez,
K.Ebata,
H.S.Randeria,
M.S.Rosendahl,
E.P.Cedervall,
T.H.Morales,
L.M.Hanson,
N.E.Brown,
X.Gong,
J.R.Stephens,
W.Wu,
I.Lippincott,
K.S.Ku,
R.A.Walgren,
P.B.Abada,
J.A.Ballard,
C.K.Allerston,
B.J.Brandhuber.
Pirtobrutinib Preclinical Characterization: A Highly Selective, Non-Covalent (Reversible) Btk Inhibitor. Blood 2023.
ISSN: ESSN 1528-0020
PubMed: 36796019
DOI: 10.1182/BLOOD.2022018674
Page generated: Fri Aug 2 19:11:03 2024
|